Subgroups
Bayer AG (Holding Company)
-
Monday - June 17, 2013
Anniversary Song Project
150 Years of Bayer: pop song for a good cause
Employee teams from various countries record "A Better Life" » more
-
Wednesday - June 5, 2013
Bayer Science & Education Foundation launches new round of funding:
Bayer foundation scholarships – EUR 200,000 for work and study abroad
Support for ambitious study projects in the fields of science, engineering, medicine and teacher training in scientific subjects / Hermann Strenger scholarships to sponsor career-training projects abroad / Applications now possible online till July 15, 2013 » more
-
Wednesday - June 5, 2013
Tender offer successful:
Bayer acquires majority interest in Conceptus
96.4 percent of Conceptus’ shares tendered / Conceptus imminently to become a wholly-owned Bayer subsidiary » more
-
Wednesday - May 29, 2013
Antitrust clearance obtained for Bayer's acquisition of Conceptus
Offer expires at midnight on June 4/5, 2013 » more
-
Thursday - May 16, 2013
Strategic move to strengthen Consumer Care business:
Bayer to acquire Steigerwald Arzneimittelwerk GmbH
Transaction includes Iberogast® and Laif® brands » more
-
Wednesday - May 15, 2013
Dr. Herbert Heitmann to be new Head of Communications and Government Relations at Bayer » more
-
Tuesday - May 14, 2013
Bayer Head of Communications will join soccer team
Michael Schade will become Managing Director of Bayer 04 Leverkusen » more
-
Tuesday - May 7, 2013
Not intended for UK Media
Bayer commences cash tender offer for all outstanding shares of Conceptus, Inc. » more
-
Tuesday - May 7, 2013
Sustainable Development Report 2012:
Bayer documents economic, social and ecological performance
Bayer CEO Dekkers: “Innovation and sustainability are the driving force behind our business success” / Integrated reporting from 2014 » more
-
Monday - April 29, 2013
Not intended for UK media - Strategic expansion of Women’s Health business:
Bayer to acquire Conceptus, Inc.
Adds Essure®, the only non-surgical permanent birth control method, to Bayer’s contraception portfolio » more
-
Friday - April 26, 2013
Annual Stockholders' Meeting 2013 » more
-
Friday - April 26, 2013
Dr. Marijn Dekkers at the Annual Stockholders’ Meeting of Bayer AG:
“Bayer is a world-class innovation company”
2012 operationally a very successful year / Highest sales in the company’s 150-year history / Proposal to raise dividend for 2012 to EUR 1.90 per share / Employees to benefit from the company’s success with bonuses totaling over EUR 700 million / Life Sciences off to a good start in anniversary year » more
-
Thursday - April 25, 2013
Bayer helps victims of earthquake in China
Monetary and material donations totaling around EUR 1.1 million » more
-
Thursday - April 25, 2013
First quarter of 2013:
Bayer: Life Sciences off to a good start in anniversary year
New pharmaceutical products spur growth at HealthCare, continuing strong development at CropScience, cost pressure at MaterialScience / Group sales up 2.1 percent to EUR 10,266 million / EBIT improves by 8.6 percent to EUR 1,771 million / EBITDA before special items increased by 0.4 percent to EUR 2,453 million / Net income rises 11.5 percent to EUR 1,160 million / Gratifying development in Emerging Markets / Group outlook for 2013 confirmed » more
-
Thursday - March 21, 2013
Press conference: opening ceremony of the Bayer art exhibition
From Beckmann to Warhol – Art of the 20th and 21st centuries – The Bayer Collection / Martin-Gropius-Bau, March 22 to June 9, 2013 » more
-
Thursday - February 28, 2013
Financial News Conference
Full Year 2012 Results » more
-
Thursday - February 28, 2013
New products create optimism for the future
Bayer: continuing growth momentum
Group targets achieved in 2012 – sales and earnings before special items increase in all subgroups / Sales increase by 8.8 percent to EUR 39,760 million / EBIT EUR 3,960 million (minus 4.6 percent) – Net income EUR 2,446 million (minus 1.0 percent) / Further accounting measures for legal claims / EBITDA before special items rises by 8.8 percent to EUR 8,284 million / Core earnings per share improve by 10.8 percent to EUR 5.35 / Encouraging growth in the emerging markets / Steady progress with innovation pipeline strengthens life-science businesses / Forecast for anniversary year 2013: continuing record development » more
-
Tuesday - February 26, 2013
Bayer proposes dividend increase to EUR 1.90 per share for 2012
Payout up 15 percent to EUR 1,571 million » more
-
Friday - February 22, 2013
New award from the Bayer Science & Education Foundation:
Bayer Thrombosis Research Award 2013 for Dr. Krystin Krauel
Research scientist at Ernst-Moritz-Arndt University Greifswald honored for her work in the field of antibacterial host defenses » more
-
Friday - January 25, 2013
Bayer foundation cooperates with Humboldt Foundation
EUR 3 million for new Humboldt-Bayer research fellowships
Financing for 10 post-doctoral fellowships a year through 2018 / Focus on the life sciences, chemistry and pharmacy » more
Copyright @ Bayer AG
Search
Publications
research – The Bayer Scientific Magazine
Stockholders' Newsletter
Annual Report
Sustainable Development Report
Publications Overview
Newsletter
Events
Download Center - Selection